Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert M Sharkey

Showing results (81-90 of 111) with videos related to

Pageof 12
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2006
Bispecific antibody pretargeting of tumor neovasculature for improved systemic radiotherapy of solid tumorsDieter Moosmayer, Dietmar Berndorff, Chien-Hsing Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Pretargeting of carcinoembryonic antigen-expressing cancers with a trivalent bispecific fusion protein produced in myeloma cellsEdmund A Rossi, Chien-Hsing Chang, Michele J Losman, et al.
EJNMMI Research|January 31, 2012
Pretargeted immuno-PET of CEA-expressing intraperitoneal human colonic tumor xenografts: a new sensitive detection methodRafke Schoffelen, Winette Ta van der Graaf, Robert M Sharkey, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 16, 2013
Pretargeted immuno-PET and radioimmunotherapy of prostate cancer with an anti-TROP-2 x anti-HSG bispecific antibodyCatharina M van Rij, Susanne Lütje, Cathelijne Frielink, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 26, 2011
Imaging of prostate cancer with immuno-PET and immuno-SPECT using a radiolabeled anti-EGP-1 monoclonal antibodyCatharina M van Rij, Robert M Sharkey, David M Goldenberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 4, 2006
Bispecific antibody pretargeting PET (immunoPET) with an 124I-labeled hapten-peptideWilliam J McBride, Pat Zanzonico, Robert M Sharkey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 30, 2011
Treatment of advanced pancreatic carcinoma with 90Y-Clivatuzumab Tetraxetan: a phase I single-dose escalation trialSeza A Gulec, Steven J Cohen, Kenneth L Pennington, et al.
Cancer Research|September 26, 2014
Pretargeted dual-modality immuno-SPECT and near-infrared fluorescence imaging for image-guided surgery of prostate cancerSusanne Lütje, Mark Rijpkema, David M Goldenberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 28, 2016
Immuno-PET Using Anticarcinoembryonic Antigen Bispecific Antibody and 68Ga-Labeled Peptide in Metastatic Medullary Thyroid Carcinoma: Clinical Optimization of the Pretargeting Parameters in a First-in-Human TrialCaroline Bodet-Milin, Alain Faivre-Chauvet, Thomas Carlier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 7, 2012
A new Tri-Fab bispecific antibody for pretargeting Trop-2-expressing epithelial cancersRobert M Sharkey, Catharina M van Rij, Habibe Karacay, et al.
Pageof 12

Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2006
Bispecific antibody pretargeting of tumor neovasculature for improved systemic radiotherapy of solid tumorsDieter Moosmayer, Dietmar Berndorff, Chien-Hsing Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Pretargeting of carcinoembryonic antigen-expressing cancers with a trivalent bispecific fusion protein produced in myeloma cellsEdmund A Rossi, Chien-Hsing Chang, Michele J Losman, et al.
EJNMMI Research|January 31, 2012
Pretargeted immuno-PET of CEA-expressing intraperitoneal human colonic tumor xenografts: a new sensitive detection methodRafke Schoffelen, Winette Ta van der Graaf, Robert M Sharkey, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 16, 2013
Pretargeted immuno-PET and radioimmunotherapy of prostate cancer with an anti-TROP-2 x anti-HSG bispecific antibodyCatharina M van Rij, Susanne Lütje, Cathelijne Frielink, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 26, 2011
Imaging of prostate cancer with immuno-PET and immuno-SPECT using a radiolabeled anti-EGP-1 monoclonal antibodyCatharina M van Rij, Robert M Sharkey, David M Goldenberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 4, 2006
Bispecific antibody pretargeting PET (immunoPET) with an 124I-labeled hapten-peptideWilliam J McBride, Pat Zanzonico, Robert M Sharkey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 30, 2011
Treatment of advanced pancreatic carcinoma with 90Y-Clivatuzumab Tetraxetan: a phase I single-dose escalation trialSeza A Gulec, Steven J Cohen, Kenneth L Pennington, et al.
Cancer Research|September 26, 2014
Pretargeted dual-modality immuno-SPECT and near-infrared fluorescence imaging for image-guided surgery of prostate cancerSusanne Lütje, Mark Rijpkema, David M Goldenberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 28, 2016
Immuno-PET Using Anticarcinoembryonic Antigen Bispecific Antibody and 68Ga-Labeled Peptide in Metastatic Medullary Thyroid Carcinoma: Clinical Optimization of the Pretargeting Parameters in a First-in-Human TrialCaroline Bodet-Milin, Alain Faivre-Chauvet, Thomas Carlier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 7, 2012
A new Tri-Fab bispecific antibody for pretargeting Trop-2-expressing epithelial cancersRobert M Sharkey, Catharina M van Rij, Habibe Karacay, et al.
Pageof 12